1. Home
  2. AX vs ABCL Comparison

AX vs ABCL Comparison

Compare AX & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axos Financial Inc.

AX

Axos Financial Inc.

HOLD

Current Price

$91.87

Market Cap

5.0B

Sector

Finance

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

SELL

Current Price

$11.19

Market Cap

4.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
AX
ABCL
Founded
1999
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
4.1B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
AX
ABCL
Price
$91.87
$11.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
13
Target Price
★ $117.71
$17.17
AVG Volume (30 Days)
332.7K
★ 3.8M
Earning Date
10-29-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 14.13
10.91
EPS
★ 2.25
N/A
Revenue
★ $81,254,000.00
$75,128,000.00
Revenue This Year
$11.96
N/A
Revenue Next Year
$9.49
$7.12
P/E Ratio
$42.03
★ N/A
Revenue Growth
23.51
★ 160.56
52 Week Low
$74.89
$2.75
52 Week High
$105.74
$14.98

Technical Indicators

Market Signals
Indicator
AX
ABCL
Relative Strength Index (RSI) 60.21 49.85
Support Level $94.35 $11.78
Resistance Level $100.94 $12.88
Average True Range (ATR) 2.34 0.90
MACD 0.60 -0.06
Stochastic Oscillator 68.62 43.72

Price Performance

Historical Comparison
AX
ABCL

About AX Axos Financial Inc.

Axos Financial Inc is a technology-driven, diversified financial services company. Its client-centric, technology-enabled services model provides secure and scalable banking, clearing and custody, and investment advisory solutions to retail and business customers. The Bank provides consumer and commercial banking products and services through its digital online and mobile banking platforms, low-cost distribution channels and affinity partners. It offers deposit and lending products to customers nationwide including consumer and business checking, savings, etc. Its segments are Banking Business Segment and the Securities Business Segment. Majority of income comes from Banking Business Segment- It distribute its loan products through its retail, correspondent and wholesale channels.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: